How precision oncology is transforming cancer care – Genomate Health
Genomate Health shared on LinkedIn:
“The future of cancer treatment is personalized, and precision oncology is leading the way. Join our Founder and CEO, Istvan Petak, on October 28, 2024, as he hosts an insightful session that explores how precision oncology is transforming cancer care – and how it’s a game-changer for life insurers.
A special thanks to the Plug and Play Tech Center team for inviting us to host this session and share our insights.
Register now to secure your spot.”
More posts featuring Genomate Health and Istvan Petak on oncodaily.com
Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC)
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023